Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E7777 + CHOP in First-Line PTCL
NCT01355783Phase 3Withdrawn
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2011
- Primary completion
- Oct 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of denileukin diftitox in peripheral T-cell lymphoma (PTCL), sponsored by Eisai Co., Ltd.. Planned start Mar 2011; status: withdrawn.
02
Drugs
denileukin diftitox
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT01355783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355783.